Polysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered release
- PMID: 21915976
- PMCID: PMC4040275
- DOI: 10.1002/anie.201104510
Polysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered release
Figures
; IC50 = (0.37 ± 0.02) μ
), APEG-1 (○), and PBS (■) administered at 5 mg Pt kg−1 on days 0, 7, and 14 against an AsPC-1 subcutaneous mouse xenograft.
References
-
- Rosenberg B, VanCamp L, Krigas T. Nature. 1965;205:698. - PubMed
-
- Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, Xie J, Kim C, Song KH, Schwartz AG, Wang LV, Xia Y. Nat Mater. 2009;8:935. - PMC - PubMed
- Lee JE, Lee N, Kim H, Kim J, Choi SH, Kim JH, Kim T, Song IC, Park SP, Moon WK, Hyeon T. J Am Chem Soc. 2010;132:552. - PubMed
- Sajja HK, East MP, Mao H, Wang YA, Nie S, Yang L. Curr Drug Discovery Technol. 2009;6:43. - PMC - PubMed
- Cheon J, Lee JH. Acc Chem Res. 2008;41:1630. - PubMed
- Liu R, Zhang Y, Zhao X, Agarwal A, Mueller LJ, Feng P. J Am Chem Soc. 2010;132:1500. - PubMed
-
- Li S, Huang L. Mol Pharm. 2008;5:496. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
